Industry

LEXINGTON, Mass.–(BUSINESS WIRE)–$AGEN #AACRIO—Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that new translational and clinical biomarker analyses from its botensilimab (BOT) immunotherapy program have been accepted for poster presentation at the American Association for Cancer Research- Immuno-Oncology (AACR-IO) Conference, taking place in Los Angeles, CA on February 18–21, 2026. The abstract, titled … [Read more…]

US$46 million investment to establish wholly owned Puerto Rico subsidiary supporting U.S. manufacturing, supply security, and long-term growth of BESREMi® (ropeginterferon alfa-2b) Company plans to obtain regulatory approval and commence operations at its Puerto Rico manufacturing facility in 2027 BURLINGTON, Mass.–(BUSINESS WIRE)–PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical company headquartered in Taiwan with deep expertise … [Read more…]

The Pistons’ first-ever partnership with a men’s health company will be showcased at the top of the Pistons’ backboard, a prime in-arena spot AUSTIN, Texas–(BUSINESS WIRE)–Rugiet, a men’s healthcare platform, today announced its designation as the official men’s Rx partner for the Detroit Pistons. The partnership marks the franchise’s first-ever collaboration in men’s health and … [Read more…]

Collaboration combines Ethris’ proprietary technology platforms with DZIF’s infectious disease research expertise to advance mRNA-based vaccines across a broad range of pathogens Agreement enables manufacturing of mRNA vaccine material by Ethris’ partners Patheon and Evonik for DZIF-led vaccine research & development MUNICH–(BUSINESS WIRE)–Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and … [Read more…]

eyonis® LCS aims to redefine lung cancer screening by supporting diagnosis at early, curable stages, while reducing false positives to avoid unnecessary follow-up procedures, and has the potential to help save hundreds of thousands of lives in the US alone eyonis® LCS is the only device capable of both detecting and characterizing lung cancer in … [Read more…]

– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, Ocrevus, in reducing disability progression in PPMS – – Fenebrutinib numerically reduced the risk of disability progression by 12% compared to Ocrevus as early as 24 weeks; additional analysis showed … [Read more…]

OMNY-AF pilot study reports 90% 12-month freedom from AFib with zero procedure-related adverse eventsi Additional data presented further reinforces the favorable and consistent safety and efficiency profile of the VARIPULSE platformii,iii,iv,v IRVINE, Calif.–(BUSINESS WIRE)–Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic … [Read more…]

Decision removes last patent hurdle as Geneoscopy advances ColoSense®, its RNA-based noninvasive colorectal cancer screening test ST. LOUIS–(BUSINESS WIRE)–Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued a … [Read more…]

FT. LAUDERDALE, Fla.–(BUSINESS WIRE)–Trividia Health, Inc., announced today that it is initiating a labeling correction which requires a modification of the Owner’s Booklets/System Instructions for Use for all TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO Blood Glucose Monitoring Systems (collectively, the “Products”) distributed in the United States, United Kingdom, Mexico, … [Read more…]

Founder and leadership team to remain in place as brand accelerates North American scale and international expansion MIAMI–(BUSINESS WIRE)–TRUBAR, the fast-growing protein bar brand known for its dessert-inspired flavors and clean ingredients, today announced the completion of its acquisition by ETi Gıda, a leading global snack company headquartered in Turkey (Türkiye). Under the terms of … [Read more…]